Seagen Inc.

Seagen Inc.verified

SGEN

Price:

$228.74

Market Cap:

$43.15B

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic b...[Read more]

Industry

Biotechnology

IPO Date

2001-03-09

Stock Exchange

NASDAQ

Ticker

SGEN

The PE Ratio as of April 2024 (TTM) for Seagen Inc. (SGEN) is -57.19

According to Seagen Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -57.19. This represents a change of 24.73% compared to the average of -45.85 of the last 4 quarters.

Seagen Inc. (SGEN) Historical PE Ratio (quarterly & annually)

How has SGEN PE Ratio performed in the past?

The mean historical PE Ratio of Seagen Inc. over the last ten years is -65.95. The current -57.19 PE Ratio has changed 8.57% with respect to the historical average. Over the past ten years (40 quarters), SGEN's PE Ratio was at its highest in in the December 2019 quarter at 189.81. The PE Ratio was at its lowest in in the June 2020 quarter at -347.63.

Quarterly (TTM)
Annual

Average

-65.95

Median

-50.10

Minimum

-299.01

Maximum

52.02

Seagen Inc. (SGEN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Seagen Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 645.44%

Maximum Annual PE Ratio = 52.02

Minimum Annual Increase = -180.21%

Minimum Annual PE Ratio = -299.01

Quarterly (TTM)
Annual
YearPE RatioChange
2022-38.89-6.81%
2021-41.73-180.21%
202052.02-117.40%
2019-299.01645.44%
2018-40.11-34.26%
2017-61.0215.11%
2016-53.0110.16%
2015-48.12-7.60%
2014-52.08-32.87%
2013-77.5752.78%

Seagen Inc. (SGEN) Average PE Ratio

How has SGEN PE Ratio performed in the past?

The current PE Ratio of Seagen Inc. (SGEN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-9.53

5-year avg

-73.54

10-year avg

-65.95

Seagen Inc. (SGEN) PE Ratio vs. Peers

How is SGEN’s PE Ratio compared to its peers?

Seagen Inc.’s PE Ratio is less than BioMarin Pharmaceutical Inc. (102.98), less than Alnylam Pharmaceuticals, Inc. (-42.35), less than Exelixis, Inc. (34.68), less than Halozyme Therapeutics, Inc. (17.96), less than Legend Biotech Corporation (-16.28), less than Zai Lab Limited (-4.76), less than Ascendis Pharma A/S (-16.08), less than Incyte Corporation (19.46), less than United Therapeutics Corporation (11.32), less than Ultragenyx Pharmaceutical Inc. (-6.06), less than Apellis Pharmaceuticals, Inc. (-11.17), greater than Viking Therapeutics, Inc. (-78.82), less than TG Therapeutics, Inc. (154.94), less than X4 Pharmaceuticals, Inc. (-2.03), less than PDS Biotechnology Corporation (-2.36), less than Madrigal Pharmaceuticals, Inc. (-11.78), less than IVERIC bio, Inc. (-33.43), less than Immunovant, Inc. (-17.26), less than Akero Therapeutics, Inc. (-7.85),

Build a custom stock screener for Seagen Inc. (SGEN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Seagen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Seagen Inc. (SGEN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Seagen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Seagen Inc.'s PE Ratio?

How is the PE Ratio calculated for Seagen Inc. (SGEN)?

What is the highest PE Ratio for Seagen Inc. (SGEN)?

What is the 3-year average PE Ratio for Seagen Inc. (SGEN)?

What is the 5-year average PE Ratio for Seagen Inc. (SGEN)?

How does the current PE Ratio for Seagen Inc. (SGEN) compare to its historical average?